|
| ICA-2010 will provide a platform for participants to: |
|
 |
Learn the latest technologies and developments for antibodies |
|
| |
Comprehend the best strategies to follow in order to optimally plan antibodies R & D |
| |
Gain insights from industry decision makers as they share their thoughts on market trend |
| |
Hear opinions from professionals about regulatory issues and policies on antibodies |
| |
Build partnerships in China and beyond to catch your targets |
| |
Find huge opportunities and markets for your business |
|
| Renowned Speakers |
|
 |
Dr. David Wenyan Shen, Executive Director and Head, Biologics Research & GlycoFi, Merck & Co., Inc., USA |
 |
Dr. Anthony (Tony) Warford , Discipline Leader, Histopathology, AstraZeneca, Innovation Center, China |
 |
Dr. Paul W.H.I. Parren, Sr. VP, Research & Pre-Clinical Development, Genmab, the Netherlands |
 |
Dr. Dennis W Harris, Corporate VP and CSO, Millipore Corporation, USA |
 |
Dr. Teodor Aastrup, CEO, Attana AB, Sweden |
 |
Dr. Masa Fujiwara, President&CEO, Chiome Bioscience Inc., Japan |
 |
Dr. Frank Zhang, CEO, GenScript Corporation, USA |
 |
Dr. Evan B. Siegel, President and CEO, Ground Zero Pharmaceuticals, Inc., USA |
 |
Dr. Andreas Baumann, Principal Scientific Expert Biologics, Bayer Schering Pharma AG, Germany |
 |
Dr. Davis Farmer, Chairman, MSM Protein Technologies, lnc., USA |
 |
Dr. Hongtao Lu, Head and Director, Neuroimmunology DPU, GSK R&D China |
 |
Dr. Michael B. Atkins, Professor of Medicine, Harvard Medical School, USA |
 |
Dr. Kakil Ibrahim Rasul,
Senior Consultant Physician in Haem/Oncology,
Al-Amal Hospital,
Qatar |
 |
Dr. Christopher J. Mann,
Senior Application Support Specialist,
Genetix , UK |
More... |
|
|
| Programmed Sessions at a Glance |
|
| |
 Event Report |
|
 |
The 1st Annual International Congress of Antibodies 2009 was hold successfully in International Convention Center, Beijing, China during May 22-24, 2009. The conference was supported by China Medicinal Biotech Association (CMBA), P.R. China; GenScript Corporation, USA; and Buchang Pharmacy Group, P.R. China.
|
 |
 |
 |
| [ More ] |
|
| Conference Exhibition |
For Sponsors |
Exhibition Date
Set-up date: March 23 (Tuesday)
Show dates:
March 24 (Wednesday)-26 (Friday), 09:00-18:00
Place: Exhibition Hall, Floor 3, Beijing International Convention Center
Space: 3m (W) x 2m (D) x 2.5m (H)
|
Exposure to 200 interested and relevant world class scientists, executives and decision makers on frontier of antibody industry and antibody R&D, and over 350 participants:
· Opportunities to focus on strategic issues in the antibody industry, explore ways to further your products and technologies, and make new contacts through several organized networking events
· Demonstrate and promote new products, introduce new services or solutions and engage face-to-face contact with your target audience |
|
|
|
Tour in Beijing & Xi' an
Beijing, as the capital city of the People's Republic of China is the nation's political and cultural center and also a center for international contacts, where People of all China's 56 ethnic groups are found. More...
Xi'an, China's ancient capital with a history dating back more than 3,000 years has become a must-see location for many tourists visiting China. The mausoleum of Qin Shi Huang, the unifier of China and its first Emperor, is home to what has become known as "the Eighth Wonder of the World," the Terracotta Warriors. This tour is a great opportunity to learn and experience a great deal of the ancient history of China. More...
If you interested in this tour, please select the package A when you register online
|
|
| Silver Sponsor |
|
|
 |
| Session Sponsor |
|
|
| Gift Sponsor |
|
|
| Key Dates |
|
| July 31, 2009 |
|
Deadline for Early Bird Registration |
| December 31, 2009 |
|
Poster Presentation Abstract Submission Deadline |
| February 25, 2010 |
|
Hotel Accommodation Cancellation |
| March 23, 2010 |
| |
Registration |
| March 24, 2010 |
| |
Congress Opening Ceremony |
|
|
|
| Exhibitors |
|
|
| Attendees list |
|
Arana Therapeutics
Attana AB
Amgen
Biogen Idec, Inc.
Bayer Schering Pharma AG
Baxter Innovations GmbH
Burrill & Company
Centocor R&D, Inc.
Crucell NV
Chiome Bioscience Inc.
Epitomics Inc.
Bioduro
GSK-Domantis Ltd.
GenScript Corporation
Genmab
Ground Zero Pharmaceuticals, Inc.
GlaxoSmithKline Biologicals
GE Heathcare Life Sciences
Human Antibodomics Inc.
Isogenica Ltd.
Intellect Neurosciences, Inc.
ImClone Systems Inc.
Medarex Inc.
MitoSciences Inc.
Millipore Corporation
MacroGenics Inc.
Merck & Co., Inc.
NPS Pharmaceuticals
Patrys Ltd.
PX'Therapeutics SA
Pfizer Global Biologics
Roche Global Pharma Partnering
Seattle Genetics, Inc.
SuppreMol GmbH
Tracon Pharma
Trillium Diagnostics, LLC
Wyeth Research |
|
|
| Organization |
|
|
|
| Supporting Organization |
|
|
| Operating |
|
 |
Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision
BIT Lifesciences, Inc. |
|
|
| International Marketing Partner |
|
|
|
| Partners |
|
|
|
|
|
Conference Venue
